USAID offers help for TB patients in more than 100 countries
Georgia is the first country that has received the free treatments. Some patients in this area have deadly strains of multi-drug resistant tuberculosis (MDR-TB). The free treatments are thanks to an innovative drug donation partnership involving Janssen Therapeutics (a pharmaceutical company under Johnson & Johnson) and USAID.
MDR-TB is a strain of TB that resists treatments from at least two out of the four most frequently used medicines. Georgia is considered a high MDR-TB burden country; 48 percent of its known TB cases have been labeled as multidrug-resistant.
Approximately 200 MDR-TB patients in Georgia will soon receive SIRTURO, a TB drug, for their treatment program. This is the first new drug for TB in over 40 years, giving patients with MDR-TB hope for better treatment options.
Program leaders are also dedicated to detecting TB earlier, controlling MDR-TB and TB with technical assistance and capacity building, and providing support for innovation and research.